ArticleNaunyn-Schmiedeberg's archives of pharmacology2026
The global surge of cocaine use disorder: a 30-year burden analysis from the GBD 2021.
Article in Naunyn-Schmiedeberg's archives of pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cocaine use disorder (CUD) represents a growing global health challenge with an inadequately characterized epidemiological profile. Utilizing data from the Global Burden of Disease (GBD) 2021 study across 204 countries or territories (1990-2021), this study assessed age-standardized incidence (ASIR), prevalence (ASPR), mortality (ASMR), and disability-adjusted life years (DALYs) rates. Key trends were analyzed using Estimated Annual Percentage Change (EAPC). Additional analyses included frontier mapping against the Socio-demographic Index (SDI), decomposition to identify driving factors, and ARIMA modeling for future projections. Findings revealed that global cocaine production tripled between 2009 and 2023, coinciding with a rising CUD burden: ASMR increased by 114% from 1990 to 2021, with males experiencing a faster mortality increase compared to females. High-income and Latin American regions bore the highest burden-the USA led in ASIR and ASMR, while Spain saw declines after 2005 due to stringent policies. SDI strongly correlated with ASIR (ρ = 0.59), and high-SDI regions had higher DALYs than low-SDI areas. Projections indicate accelerating ASMR and DALY rates in high-income countries by 2036. CUD imposes an escalating and inequitable global burden, disproportionately affecting males, high-income populations, and the Americas. Addressing this crisis requires targeted interventions and improved surveillance of evolving use patterns and comorbidities.
Indexed as
Identifiers
42864502What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.